ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication

Oncotarget. 2016 Oct 25;7(43):70323-70335. doi: 10.18632/oncotarget.11855.

Abstract

ATAD2 (ATPase family AAA domain-containing protein 2) is a chromatin regulator harboring an AAA+ ATPase domain and a bromodomain, previously proposed to function as an oncogenic transcription co-factor. Here we suggest that ATAD2 is also required for DNA replication. ATAD2 is co-expressed with genes involved in DNA replication in various cancer types and predominantly expressed in S phase cells where it localized on nascent chromatin (replication sites). Our extensive biochemical and cellular analyses revealed that ATAD2 is recruited to replication sites through a direct interaction with di-acetylated histone H4 at K5 and K12, indicative of newly synthesized histones during replication-coupled chromatin reassembly. Similar to ATAD2-depletion, ectopic expression of ATAD2 mutants that are deficient in binding to these di-acetylation marks resulted in reduced DNA replication and impaired loading of PCNA onto chromatin, suggesting relevance of ATAD2 in DNA replication. Taken together, our data show a novel function of ATAD2 in cancer and for the first time identify a reader of newly synthesized histone di-acetylation-marks during replication.

Keywords: ATAD2; DNA replication; bromodomain; cancer; histone acetylation.

MeSH terms

  • ATPases Associated with Diverse Cellular Activities / physiology*
  • Acetylation
  • DNA Replication*
  • DNA-Binding Proteins / physiology*
  • Epigenesis, Genetic*
  • HEK293 Cells
  • Histone Code*
  • Histone Deacetylase 1 / metabolism
  • Histones / metabolism
  • Humans

Substances

  • DNA-Binding Proteins
  • Histones
  • HDAC1 protein, human
  • Histone Deacetylase 1
  • ATAD2 protein, human
  • ATPases Associated with Diverse Cellular Activities